As we move through the first month of 2026, the global response to high-consequence pathogens has entered a sophisticated new phase. A detailed Plague Market analysis reveals that while Yersinia pestis remains a rare clinical occurrence, the infrastructure supporting its detection and prevention has expanded into a multi-billion dollar biosecurity ecosystem. The market, which was valued at...